Novel phosphate triester derivatives of the antiviral drug araA and the anti-leukaemic agent araC have been prepared as membrane-soluble pro-drugs of the bio-active free nucleotides. In particular, novel trichloro-and trifluoroethyl phosphates have been prepared using phosphorochloridate chemistry, and are fully characterized. An in vitro assay indicates inhibition, by each of the compounds, of thymidine incorportion by mammalian epithelial cells. It is notable that the trichloroethyl derivative is most active in each case, and in the case of araC its activity appears to exceed that of the parent nucleoside.
Introduction
Although widely used in the chemotherapy of cancer and of viral infections, nucleoside analogues have a number of limitations. These arise in part from the absolute necessity for kinase-mediated activation of the nucleoside drugs. The potential advantages of circumventing the nucleoside kinase by using masked phosphate pro-drugs have been described (Chawla et aI., 1984; Hunston et aI., 1984; Farquhar and Smith, 1985; Gouyette et aI., 1989) . In the case of the anti-herpetic drug araA (vidarabine; 1)we have found (McGuigan et al., 1989a,b ) that simple 5'-dialkyl phosphate derivatives are resistant to chemical and enzymic degradation and yet exert an effect on DNA synthesis by mammalian cells. The same observation was subsequently noted for the anti-leukaemic agent araC (cytarabine; 3) (Jones et aI., 1989) . Moreover, in both cases, a clear relationship exists between increasing alkyl chain length and biological activity. We attribute this to increasing lipophilicity, and hence improved membrane penetration, with increasing chain length. In order to probe the mechanism of action of these compounds, we prepared phosphinate analogues in which the (labile) P-Oalkyl groups were replaced by (stable) P-GH 2-alkyl moieties. In every case, the biological activity was significantly reduced on going from the phosphate to the analogous phosphinate (McGuigan et al., 1989b) ; which suggests that P-O-alkyl bond cleavage, and release of nucleotides, are a major mechanism by which the compounds act. Thus, in order to enhance the cleavage of the alkyl phosphate groups, we probed the substitution of electron withdrawing groups within the alkyl chains. We herein report the application of this strategy to both araA and araC, with the preparation of the 5'-bis(2,2,2-trichloroethyl)-, and 5'-bis(2,2,2-trifluoroethyl)-phosphate triester derivatives.
Results
The synthetic strategy adopted for the target compounds involved the prior synthesis of the appropriate phosphorochloridate and its reaction with a suitable nucleoside analogue (Fig. 1 ). This was based on the success of this strategy for halogen-substituted, alkyl phosphate derivatives of the anti-HIV agents AlT and ddCyd (McGuigan et aI., 1990) . Thus, bis(2,2,2-trifluoroethyl)phosphorochloridate was prepared by the reaction of trifluoroethanol and phosphoryl chloride in ether at low temperature, inthe presence of triethylamine (Kosolapoff, 1950 ). This gives a single peak in the 31 P NMR at 3 +6, as expected for such a compound (Mark et al., 1969) .The 13C NMR is particularly. informative, the downfield CF 3 signal displaying very large (280Hz) fluorine coupling, and small phosphorus coupling. Reaction of this reagent with araA (1} in pyridine at ambient temperature yields the target triester (2a).This displays a single peak in the 31p NMR, somewhat further upfield (3-2) than previously noted for simple' dialkyl phosphate triesters of araA (McGuigan et aI., 1989a) , but entirely consistent with the structure (Mark et al., 1969) . Proton and 19F NMR data were also consistent with the structure of 2a. Electron impact mass spectrometry revealed a weak MH+ peak, which was more intense in the FAB spectrum. A similar reaction of the phosphorochloridate with araC (3) gave the analogous derivative 4a. This CF3CH2-0-P-0\;j I 0 HO HO OH revealed very similar spectroscopic data to 2a. Extensive heteronuclear coupling was noted in the 13C NMR of 4a, fluorine coupling to the GF 3 and GH 20P atoms, and phosphorus coupling to these carbon atoms and to the 5' and 4' sites.
The araA and araC derivatives 2b and 4b respectively were similarly prepared using commercial bis(2,2,2-trichloroethyl)phosphorochloridate. These displayed similar spectroscopic data to the earlier analogues 2a and 4a, although the absence of the trifluoro group simplified the NMR data. In the 13C spectrum the CCI 3 moiety was not so far downfield as the CF 3 group (Mariano et al., 1979) (3 96 vs. 126), although it displayed a somewhat larger phosphorus coupling (11 Hz) than any other phosphorus-coupled atom.
It seemed likely that halogenation of the alkyl phosphate groups would labilize the phosphate moiety towards hydrolysis; the hope being that this might enhance their biological activity. In order to test their stability, compounds 2a and 2b were incubated in water at 37"C. Under such conditions simple dialkyl phosphate triesters were Each of the compounds tested significantly inhibits DNA synthesis in this assay, and in every case a clear doseresponse effect is noted. In each case, the trichloroethyl compounds are more active than their trifluoroethyl analogues; this is particularly noticeable in the araC case (4a vs. 4b). This was surprising, given the apparent lability of the fluoro compounds as detailed above, and the possible enhanced intracellular hydrolysis in this case. Interestingly, we have recently noted just such a preference for the trichloroethyl moiety over the trifluoro group in the case of analogous phosphate triester derivatives of the anti-HIV nucleoside analogue AZT (McGuigan et aI., 1990) . One factor which might mitigate in favour of the trichloroethyl group is the enhanced lipophilicity which this group might confer. Indeed, in both araA and araC cases we have previously noted a clear and direct correlation between lipophilicity and biological activity (McGuigan et al., 1989a; Jones et al., 1989) . In order to probe this, the octanol-water partition coefficients (P) were determined for 2a and 2b; the data are shown in Table 1 . As expected 2b is rather more lipophilic than 2a. We therefore wondered how these haloethyl analogues compared to their simple alkyl parent compounds. Thus, in Figure 2 we plot the percentage inhibition ofDNA synthesis against P, for 2a and 2b and for the simple diethyl 6a, dipropyl 6b, dibutyl 6c, and dipentyl 6d phosphate triesters of araA (McGuigan et el., 1989a) . The trifluoro compund 2a is intermediate in P value between 6a and 6b, but signifi-Discussion entirely stable over several months (McGuigan et a/., 1989a,b; Jones et a/., 1989) . In the case of the chloro compound 2b 31 P NMR revealed no reaction over one week. However, the fluoro analogue 2a was much more labile. No starting material remained after one week, with a single new phosphorus NMR resonance noted, close to the reference peak. On proton-coupling this signal spilt into a quintet. The product was neither araA (1) nor the 5'-monophosphate araAMP, as revealed by NMR and TLC evidence. These data suggest structure 5, the trifluoroethyl araA phosphate diester this sole hydrolysis product. Although not isolated or fully characterized, this hydrolysis solution was included in the biological assay, to examine whether (extracellular) hydrolysis adversely or beneficially affected the activity of the parent compound 2a. Thus, compounds 1, 2a and 2b, 3, 4a, and 4b and (crude) 5 were tested for their ability to inhibit the incorporation of tritiated thymidine into mammalian DNA in tissue culture, by methods we have previously described (Jones et al., 1989; McGuigan et a/., 1989a,b) . Data were obtained at three concentrations (3, 30, and 150 fLM) and with incubation times of 30 and 60 min. The results are displayed in Fig. 1a and 1b . cantly exceeds the activity of 6b; it is more active than its Iipophilicity alone would confer. Similarly, the chiaro analogue 2b has a P value just slightly less than 6b, but it?
activity greatly exceeds that of 6b. Indeed, the discrepancy here is very great; 2b is almost as active as 6c (within the errors they are indistinguishable) and yet 6c is mare than twice as lipophilic. This effect is very marked, and is attributed to the presence of the halogen substituents, and their labilizing effect on the phosphate moiety. However, as we noted above, this labilization is much more marked for the fluoro compounds than for the chloro analogues; a distinction which is not maintained, and is perhaps even inverted, in terms of the relative biological activity of 2a and 2b. One possible explanation of this would be if the trifluoro compound is highly labile, and liberates (polar) nucleotides prior to membrane penetration. In this connection, it is of great interest to note that the hydrolysis product 5, derived from 2a is very much less active than 2a.
In conclusion we have demonstrated that the introduction of bis(trihaloethyl) substituents at the phosphate site can enhance lipophilicity, increase lability towards hydrolysis and increase biological activity, and that the relative magnitude of these effects varies markedly with the nature of the halogen substituent. The bis(trichloroethyl)phosphate of araC is more active than the parent nucleoside. This suggests that alternative phosphate blocking groups might significantly enhance the biological properties of therapeutic nucleoside analogues, and that such derivatives might act as intracellular sources of the free nucleotides.
(32-63 mesh) as the stationary phase. The ratio of silica-compound varied between 50: 1 and 100: 1 (w/w). Analytical HPLC was carried out on an ACS quaternary system, using a Spherisorb CN 5 fLM column and an eluant of 5% water in MeCN, with a flow rate of 2 ml mln" anddetection by UVat 265 nm. Phosphorus-31 NMR spectra were recorded on a Varian XL-200 spectrometer operating at 82 MHz and are reported in units of II relative to 85% phosphoric acid as external standard, positive shifts are downfield. Carbon-13 NMR spectra were recorded on a Varian XL-200 spectrometer operating at 50 MHz or a Varian VXR-400 spectrometer operating at 100 MHz and are reported in units of II relative to CDCIs at 77.00 ppm. Both phosphorus-31 and carbon-13 NMR spectra were proton noise decoupled and all signals were singlets unless otherwise stated. H-1 NMR spectra were recorded on a Varian XL-200 spectrometer operating at 200 MHz or a Varian VXR-400spectrometer operating at 400 MHz and are reported in units of II relative to internal CHCIs at 7.24 ppm unless otherwise stated. The 19F NMR spectrum was run on a Varian VXR-400 operating at 376 MHz. All NMR spectra were recorded in CDCIs unless otherwise stated. FAB mass spectra were recorded on a VG Zab1F spectrometer courtesy of the University of London Mass Spectrometry service. Microanalyses were performed at University College London in the laboratory of Mr A. Stones; the nucleotides were noted to be hygroscopic, and data are presented appropriately. All experiments involving water sensitive reagents were carried out under scrupulously dry conditions. Where needed, anhydrous solvents and reagents were obtained in the following ways: Diethyl ether, pyridine, and triethylamine were refluxed over CaH 2 for several hours and distilled. Ether and pyridine were further dried over activated 4ft.. Table 1 . Octanol-water partition coefficients (P) for nucleotide derivatives.
Materials and Experimental procedures: Chemistry
Commerically available Merck kieselgel F254 plates were used for the TLC and the components were visualized by ultraviolet light. Column chromatography was carried out using Woelm silica Compound 2a 2b 6a 6b 6c 6d P 2.7 6.7 0.6 7.0 15.9 19.8 molecular sieves. Trifluoroethanol and phosphoryl chloride were distilled prior to use, the former being further dried over sieves. 2, Compound 1 (1.0g, 3.74 mmol) was dissolved in pyridine (120 ml), and bis-(2,2,2-trifluoroethyl)phosphorochloridate (2.10g, 7.48 mmol) added dropwise with vigorous stirring at ambient temperature. After stirring for 4 h, the reaction was quenched with water (135 ul, 7.48 mmol) , and the solvent was removed under reduced pressure. The resulting oil was dried in a vacuum, and purified by flash column chromatography on silica. Elution with 10% methanol in chloroform, followed by pooling and evaporation of appropriate fractions gave the product as a gum, which was triturated with diethyl ether to yield the product as a white powder (0.90g, 47%).IlH (D 20) 8.06 (1 H, s, H2 or H8), 7.98 (1H, s, H2 or H8), 6.20 (1H, d, H1'), m, CH 20P, H2'), m, H5', H4', H3') ; IIp (CHsOD) -1.86; llF (CDsOD) -75.49 (t, CF s, J = 8.8Hz); FAB MS m/e 513 (H 2M+, 5%), 512 (MW, 19) , 250 (araA-OH, 6),178 (5),164 (7),136 (Adel-l:", 100), 121 (5), 97 (4); Found C 32. 95%, H 3.29, N 13.75, P 6.09, C14H1aFaNs07P requires C 32.89, H 3.15, N 13.70, 2, This was prepared by a method entirely analogous to that used for 2a above, except that the reaction was stirred for 2.5h, and the column was eluted with 5% methanol in chloroform. Thus from 1.0g of compound (1) 63, CI 34.58, N 11.23, P 5.15, C14H1aCIaNs07P requires C 27.57, H 2.64, CI 34.87: N 11.48, P 5 .08. -5'-bis(2,2,2-trifluoroethyljphosphate (4a) This was prepared by a method entirely analogous to that used for 2a above, except that the reagents were added at 4°C and the reaction was stirred for 17 h at ambient temperature. Thus from Haloalkyl phosphates of araA and araC 83 1-{3-D-Arabinofuranosylcytosine-5'-bis (2,2,2-trichloroethyljphosphate (4b) This was prepared by a method entirely analogous to that used for 4a above, except that 50% more phosphorylating agent was added after 17 h, stirring was continued for a further 2 h, and two chromatographic columns were used; firstly eluted with 15%, then 10% methanol in chloroform. Thus from 1.0g of compound 3, was isolated 1.48g (63%) of 4b.ll H (CDsOD) 7.75 (1H, d, H6, J = 7.5 Hz), 6.16(1H, d, H1',J = 3.5 Hz), 5.79 (1H, d, H5 ,J = 7.5Hz), 4.66 (4H, 2 x d, CH 20P, J = 4.1, 4.1 Hz), 3.98-4.48 (5H, m, H5', H4', H2', H3'); IIp (CDsOD) -2.34; llc (CDsOD) 167.60 (C4), 158.15 (C2), 144.69 (C6), 96.02 (d, cci; J = 11.3Hz), 94.90 (C5), 88.81 (C1'), 84.47 (d, C4', J = 6.6 Hz), 78.48 (d, CH 20P, J = 4.4 Hz), 78.06 (C2'), 76.12 (C3'), 70.04 (d, C5', J = 6.0Hz); FAB MS m/e 594 (0.2),593 (0.2),592 (1),591 (0.5),590 (4),589 (1),588 (10),587
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1-{3-D-Arabinofuranosylcytosine
(2),586 (12),585 (M+, 1 x s7CI, 1), 584 (7),112 (cytosine W, 100);
Found C 25.91 %, H 2.94, N 6.57; CS2H1aNsClaOaP.H20 requires C 25.85, H 3.01, N 6.96.
Materials and Experimental procedures: Tritiated thymidine incorporation assay
This assay was conducted in accordance with the procedure that we have recently reported (Jones et al., 1989) , using incubation times of 30 and 60 min.
